The Approach to High Risk Bladder Cancers in the Absence of Bacillus Calmette Guerin: What should Be the Treatment and Follow Up?

dc.authorwosidTürkeri, Levent N./W-9283-2018
dc.contributor.authorTürker, Polat
dc.contributor.authorTürkeri, Levent
dc.date.accessioned2022-05-11T14:36:58Z
dc.date.available2022-05-11T14:36:58Z
dc.date.issued2014
dc.departmentFakülteler, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Üroloji Ana Bilim Dalı
dc.description.abstractBacillus Calmette Guerin (BCG), is the optimal bladder-sparing treatment option for patients with high-risk, non-muscle invasive bladder cancer. Recently, the application of BCG has been hindered due to the problem of its availability in Turkey. Alternative treatment options are needed until this problem is solved. In this article, the recommendations about the preferred treatment options and the follow-up, are summarized in the light of the current literature.
dc.identifier.doi10.4274/UOB.09
dc.identifier.endpage108
dc.identifier.issn2147-2270
dc.identifier.issue2en_US
dc.identifier.startpage103
dc.identifier.urihttps://doi.org/10.4274/UOB.09
dc.identifier.urihttps://hdl.handle.net/20.500.11776/8510
dc.identifier.volume13
dc.identifier.wosWOS:000219410600009
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.institutionauthorTürker, Polat
dc.language.isotr
dc.publisherGalenos Yayincilik
dc.relation.ispartofUroonkoloji Bulteni-Bulletin of Urooncology
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectBBCG
dc.subjecthigh risk non-muscle invasive bladder cancer
dc.subjectEMDA
dc.subjectthermo-chemotherapy
dc.titleThe Approach to High Risk Bladder Cancers in the Absence of Bacillus Calmette Guerin: What should Be the Treatment and Follow Up?
dc.typeReview Article

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
8510.pdf
Boyut:
88.49 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text